Cover Image

Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors

Erlotinib is a highly specific and reversible epidermal growth factor receptor tyrosine kinase inhibitor for the targeted therapy of non-small-cell lung cancer (NSCLC) However, the efficacy of erlotinib is limited because the development of drug resistance during chemotherapy. Indoleamine 2,3-dioxyg...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xi-xi Hou (Author), Xiao-qing Gong (Author), Long-fei Mao (Author), Ge Sun (Author), Jian-xue Yang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies
by: Gui-Qing Xu, et al.
Published: (2022)

Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives
by: Long-fei Mao, et al.
Published: (2022)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
by: Long-fei Mao, et al.
Published: (2020)

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
by: Peng Deng, et al.
Published: (2022)

Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors
by: Xixi Hou, et al.
Published: (2022)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
by: Xi-Xi Hou, et al.
Published: (2023)

Modified Synthesis of Erlotinib Hydrochloride
by: Leila Barghi, et al.
Published: (2012)

Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
by: Shushan Ge, et al.
Published: (2020)

Design, synthesis and evaluation of a series of potential prodrugs of a Bruton's tyrosine kinase (BTK) inhibitor
by: Zhou-Peng Xiao, et al.
Published: (2023)

Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation
by: Xi Xu, et al.
Published: (2019)

A rapid and convenient method for synthesis of anilinoquinazoline: an improved synthesis of erlotinib derivatives
by: Zahra Haghighijoo, et al.
Published: (2015)

A rapid and convenient method for synthesis of anilinoquinazoline: an improved synthesis of erlotinib derivatives
by: Zahra Haghighijoo, et al.
Published: (2015)

A rapid and convenient method for synthesis of anilinoquinazoline: an improved synthesis of erlotinib derivatives
by: Zahra Haghighijoo, et al.
Published: (2015)

Design, synthesis, and biological evaluation of benzoheterocyclic sulfoxide derivatives as quorum sensing inhibitors in Pseudomonas aeruginosa
by: Shen Mao, et al.
Published: (2023)

Design, Synthesis, and Biological Evaluation of PKD Inhibitors
by: Marie-Céline Frantz, et al.
Published: (2011)

Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors
by: Jiang Yu, et al.
Published: (2022)

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
by: Yi Le, et al.
Published: (2020)

IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma
by: Zikang Xing, et al.
Published: (2024)

Design, synthesis and evaluation of novel small molecules acting as Keap1-Nrf2 protein-protein interaction inhibitors
by: Yunfeng Sun, et al.
Published: (2022)

Design, synthesis and biological evaluation of novel histone deacetylase inhibitors based on virtual screening
by: Hui Lu, et al.
Published: (2011)

Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors
by: Lingyue Zhao, et al.
Published: (2022)

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors
by: Shanbo Yang, et al.
Published: (2022)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
by: Zhendong Song, et al.
Published: (2021)

Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
by: Sreenivasulu Godesi, et al.
Published: (2023)

Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
by: Rongshuang Luo, et al.
Published: (2021)

Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors
by: Longjia Yan, et al.
Published: (2022)

Design, Synthesis, and Neuroprotective Effects of Novel Cinnamamide-Piperidine and Piperazine Derivatives
by: Jia-Yi Li, et al.
Published: (2023)

Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
by: Xuewei Cheng, et al.
Published: (2017)

N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation
by: Wei-Yi Li, et al.
Published: (2020)

Cutaneous leukocytoclastic vasculitis associated with erlotinib
by: Takahiro Sawada, et al.
Published: (2016)

A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma
by: Guangwei Xu, et al.
Published: (2018)

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
by: Xiaowei Wu, et al.
Published: (2021)

Design, Synthesis and Biological Evaluation of Aromatase Inhibitors Based on Sulfonates and Sulfonamides of Resveratrol
by: Marialuigia Fantacuzzi, et al.
Published: (2021)

Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells
by: Dahong Yao, et al.
Published: (2023)

Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors
by: Man Yang, et al.
Published: (2022)

Design, synthesis, and biological evaluation of (thio)urea derivatives as potent Escherichia coli β-glucuronidase inhibitors
by: Keren Xu, et al.
Published: (2024)

Design, synthesis and evaluation of dihydro-1H-indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
by: Shengtao Xu, et al.
Published: (2023)

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
by: Ute F. Röhrig, et al.
Published: (2022)

Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome
by: Chuan Hu, et al.
Published: (2023)

Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs
by: Qiaohua Qin, et al.
Published: (2022)